§ Funding Round
Series A funding round for Third Arc Bio raising $170M in July 2024
Series A funding round for Third Arc Bio raising $170M in July 2024
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
Vida VenturesLEAD | Organization | — |
AbbVie Ventures | — | — |
| Organization | — | |
BVF Partners | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Goldman Sachs | — | — |
| Organization | — | |
Janus Henderson Investors | — | — |
Logos Capital | — | — |
Marshall Wace | — | — |
| Angel | francesco draetta | |
| Angel | loretta tse | |
T. Rowe Price Associates | — | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$274M
Top Valuation
-
Third Arc Bio raised $170M in a Series A round.
The round was announced on 07/01/24.
The round was led by Vida Ventures, cormorant asset management, Hillhouse Capital Group.
